BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $217,620,000 | +4.3% | 1,439,571 | +0.5% | 0.01% | 0.0% |
| Q2 2022 | $208,723,000 | +23.8% | 1,432,458 | +0.8% | 0.01% | +50.0% |
| Q1 2022 | $168,573,000 | -10.7% | 1,421,726 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $188,673,000 | -1.4% | 1,369,091 | -0.6% | 0.00% | -20.0% |
| Q3 2021 | $191,414,000 | +49.2% | 1,377,981 | +4.3% | 0.01% | +66.7% |
| Q2 2021 | $128,268,000 | +47.4% | 1,321,270 | +3.8% | 0.00% | +50.0% |
| Q1 2021 | $87,002,000 | -11.6% | 1,272,896 | +10.9% | 0.00% | -33.3% |
| Q4 2020 | $98,417,000 | +44.1% | 1,148,241 | +9.3% | 0.00% | +50.0% |
| Q3 2020 | $68,294,000 | -37.9% | 1,050,502 | -30.2% | 0.00% | -50.0% |
| Q2 2020 | $110,015,000 | +131.8% | 1,504,787 | +7.9% | 0.00% | +100.0% |
| Q1 2020 | $47,455,000 | -13.8% | 1,394,516 | +38.0% | 0.00% | 0.0% |
| Q4 2019 | $55,033,000 | +47.8% | 1,010,884 | +13.3% | 0.00% | +100.0% |
| Q3 2019 | $37,223,000 | -26.4% | 892,245 | -22.7% | 0.00% | -50.0% |
| Q2 2019 | $50,545,000 | +14.2% | 1,154,257 | +34.2% | 0.00% | 0.0% |
| Q1 2019 | $44,272,000 | +79.2% | 860,159 | +28.7% | 0.00% | +100.0% |
| Q4 2018 | $24,711,000 | +22.7% | 668,236 | +24.6% | 0.00% | 0.0% |
| Q3 2018 | $20,146,000 | -1.2% | 536,511 | +4.0% | 0.00% | 0.0% |
| Q2 2018 | $20,382,000 | +175.7% | 515,726 | +79.7% | 0.00% | – |
| Q1 2018 | $7,392,000 | +46.9% | 286,950 | +53.9% | 0.00% | – |
| Q4 2017 | $5,031,000 | -0.9% | 186,463 | +37.3% | 0.00% | – |
| Q3 2017 | $5,078,000 | +58.6% | 135,848 | +6.0% | 0.00% | – |
| Q2 2017 | $3,202,000 | – | 128,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |